Clinical Trial Update: KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating KPT-9274 in patients with relapsed or refractory acute myeloid leukemia has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• KPT-9274 (KPT-9274)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse | Phase 1 | Status: COMPLETED | Results posted: 2026-01-27